Caricamento...
A novel form of 4-1BBL prevents cancer development via non-specific activation of CD4(+) T and Natural Killer cells
Costimulation through 4–1BB (CD137) receptor generates robust CD8(+) T effector and memory responses. The only known ligand, 4–1BBL, is a trimeric transmembrane protein that has no costimulatory activity as a soluble molecule. Thus, agonistic antibodies to the receptor have been used for cancer immu...
Salvato in:
| Pubblicato in: | Cancer Res |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6450554/ https://ncbi.nlm.nih.gov/pubmed/30770367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-2401 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|